Boston Scientific | BSX - Bruttoergebnis Vom Umsatz

Aktienkurs
56.81
Täglich Wechseln
0.89 1.59%
Monatlich
-6.85%
Jährlich
-46.68%
Q2 Prognose
51.62




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 5.86B 675M 2026-03
AtriCure USD 109.31M 3.97M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
CONMED USD 183.45M 34.84M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Danaher USD 3.59B 375M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Illumina USD 721M 38M 2026-03
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Masimo USD 250.8M 3.5M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12